A Phase 2, Single Arm, European Multi-center Trial Evaluating the Efficacy of Afatinib as First-line or Later-line Treatment in Advanced Chordoma.
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Afatinib (Primary)
- Indications Germ cell and embryonal neoplasms
- Focus Therapeutic Use
- 22 Aug 2017 Planned initiation date changed from 1 Jun 2017 to 1 Oct 2017.
- 22 Mar 2017 New trial record